Jane Street
SANA icon

Jane Street’s Sana Biotechnology SANA Stock Holding History

Jane Street’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16,100
Closed -$87.9K – 10306
2024
Q2 		$87.9K Buy
16,100
+600
+4% +$4.78K ﹤0.01% 8778
2024
Q1 		$155K Buy
+15,500
New +$116K ﹤0.01% 8330

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return

Jane Street's SANA Position: Q1 2026 in Review

Jane Street reduced its Sana Biotechnology (SANA) stake by 80% in Q1 2026, selling an estimated $2.11M and leaving 132,715 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #8656.

Jane Street first reported a position in SANA in Q2 2022 and has held it in 15 quarters since. The position peaked at $2.72M in Q4 2025. 202 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

  • Jane Street held 132,715 shares of Sana Biotechnology worth $382K as of Q1 2026.
  • Jane Street sold 536,169 Sana Biotechnology shares in Q1 2026, an estimated $2.11M.
  • Sana Biotechnology made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #8656 holding.
  • Jane Street first reported a position in Sana Biotechnology in Q2 2022 and has held it in 15 quarters since.
  • Jane Street's Sana Biotechnology position peaked at $2.72M in Q4 2025.
  • 202 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.